lactoferrinFinding
Lactoferrin decreases necrotising enterocolitis incidence
lowersVery limited evidenceFinding
01 · The sentence it was drawn from
“Trial results show that lactoferrin supplementation to enteral feeds decreased late-onset sepsis (typical risk ratio (RR) 0.59, 95% confidence interval (CI) 0.40 to 0.87; typical risk difference (RD) -0.06, 95% CI -0.10 to -0.02; number needed to treat for an additional beneficial outcome (NNTB) 17, 95% CI 10 to 50; six trials, 886 participants; low-quality evidence) and NEC stage II or III (typical RR 0.40, 95% CI 0.18 to 0.86; typical RD -0.04, 95% CI -0.06 to -0.01; NNTB 25, 95% CI 17 to 100; four studies, 750 participants; low-quality evidence).”
lactoferrin
Necrotising enterocolitis incidence
lowers
Effect as reported
0.4risk ratio
CI 0.18 to 0.86
- Who
- n = 750 · preterm neonates, lactoferrin added to enteral feeds (4 trials pooled); NEC counted at stage II or III
- Dose studied
- not reported
Very limited evidencePMID 28658720 · 2017
02 · The study
- Study
- meta-analysis
- Participants
- 750
- Duration
- not reported
Evidence, by strength
- strong
- moderate
- limited
- very limitedthis finding
- insufficient
03 · The paper
The Cochrane database of systematic reviews04 · To cite this finding
This address does not changehttps://catalystproject.ai/e/01M7MA14YKQB33NMXWQGGAW9Y2